Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.38 CHF | 11.63% |
| 2022 | -0.43 CHF | -86.96% |
| 2021 | -0.23 CHF | 51.06% |
| 2020 | -0.47 CHF | 28.79% |
| 2019 | -0.66 CHF | 42.11% |
| 2018 | -1.14 CHF | 39.36% |
| 2017 | -1.88 CHF | 41.07% |
| 2016 | -3.19 CHF | 98.59% |
| 2015 | -226.97 CHF | -134.72% |
| 2014 | -96.70 CHF | 9.31% |
| 2013 | -106.63 CHF | -132.41% |
| 2012 | -45.88 CHF | 84.06% |
| 2011 | -287.82 CHF | -1191.25% |
| 2010 | -22.29 CHF | 94.14% |
| 2009 | -380.59 CHF | 4.62% |
| 2008 | -399.02 CHF | -275.9% |
| 2007 | -106.15 CHF | 80.43% |
| 2006 | -542.49 CHF | -17.52% |
| 2005 | -461.63 CHF | -6.0% |
| 2004 | -435.51 CHF | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 CHF | 0.0% |
| 2023 Q2 | -0.14 CHF | -100.0% |
| 2023 Q1 | -0.07 CHF | 78.13% |
| 2023 Q4 | -0.24 CHF | -100.0% |
| 2023 Q3 | -0.12 CHF | 14.29% |
| 2023 FY | - CHF | 11.63% |
| 2022 Q4 | -0.32 CHF | -100.0% |
| 2022 FY | - CHF | -86.96% |
| 2022 Q1 | -0.06 CHF | 76.09% |
| 2022 Q2 | -0.11 CHF | -100.0% |
| 2022 Q3 | -0.16 CHF | -45.45% |
| 2021 Q2 | -0.00 CHF | -100.0% |
| 2021 Q1 | -0.00 CHF | 99.29% |
| 2021 Q3 | -0.11 CHF | -3566.67% |
| 2021 Q4 | -0.23 CHF | -109.09% |
| 2021 FY | - CHF | 51.06% |
| 2020 Q3 | -0.11 CHF | 54.17% |
| 2020 FY | - CHF | 28.79% |
| 2020 Q4 | -0.21 CHF | -90.91% |
| 2020 Q1 | -0.13 CHF | 61.76% |
| 2020 Q2 | -0.24 CHF | -84.62% |
| 2019 FY | - CHF | 42.11% |
| 2019 Q2 | -0.30 CHF | -66.67% |
| 2019 Q3 | -0.18 CHF | 40.0% |
| 2019 Q1 | -0.18 CHF | 48.57% |
| 2019 Q4 | -0.34 CHF | -88.89% |
| 2018 FY | - CHF | 39.36% |
| 2018 Q3 | -0.35 CHF | -9.37% |
| 2018 Q2 | -0.32 CHF | 0.0% |
| 2018 Q4 | -0.35 CHF | 0.0% |
| 2018 Q1 | -0.32 CHF | 46.67% |
| 2017 Q2 | -0.56 CHF | 0.0% |
| 2017 Q4 | -0.60 CHF | 0.0% |
| 2017 Q1 | -0.56 CHF | 12.5% |
| 2017 Q3 | -0.60 CHF | -7.14% |
| 2017 FY | - CHF | 41.07% |
| 2016 Q2 | -1.34 CHF | 0.0% |
| 2016 Q3 | -0.64 CHF | 52.24% |
| 2016 FY | - CHF | 98.59% |
| 2016 Q1 | -1.34 CHF | -74.03% |
| 2016 Q4 | -0.64 CHF | 0.0% |
| 2015 FY | - CHF | -134.72% |
| 2015 Q4 | -0.77 CHF | 0.0% |
| 2015 Q3 | -0.77 CHF | -37.5% |
| 2015 Q2 | -0.56 CHF | 0.0% |
| 2015 Q1 | -0.56 CHF | 0.0% |
| 2014 FY | - CHF | 9.31% |
| 2013 Q3 | -33.99 CHF | 5.77% |
| 2013 Q4 | -37.11 CHF | -9.18% |
| 2013 Q2 | -36.07 CHF | -38.52% |
| 2013 FY | - CHF | -132.41% |
| 2013 Q1 | -26.04 CHF | -83.12% |
| 2012 Q4 | -14.22 CHF | 52.28% |
| 2012 Q1 | 37.96 CHF | 193.5% |
| 2012 FY | - CHF | 84.06% |
| 2012 Q2 | -21.40 CHF | -156.38% |
| 2012 Q3 | -29.80 CHF | -39.25% |
| 2011 Q2 | -72.39 CHF | 11.12% |
| 2011 FY | - CHF | -1191.25% |
| 2011 Q4 | -40.60 CHF | 56.53% |
| 2011 Q3 | -93.39 CHF | -29.01% |
| 2011 Q1 | -81.45 CHF | 20.0% |
| 2010 Q2 | 230.20 CHF | 493.84% |
| 2010 Q1 | -58.45 CHF | -212.23% |
| 2010 Q3 | -92.04 CHF | -139.98% |
| 2010 FY | - CHF | 94.14% |
| 2010 Q4 | -101.81 CHF | -10.61% |
| 2009 Q1 | -180.65 CHF | 0.0% |
| 2009 Q2 | -94.86 CHF | 47.49% |
| 2009 Q4 | -18.72 CHF | 78.33% |
| 2009 Q3 | -86.38 CHF | 8.94% |
| 2009 FY | - CHF | 4.62% |
| 2008 FY | - CHF | -275.9% |
| 2007 FY | - CHF | 80.43% |
| 2006 FY | - CHF | -17.52% |
| 2005 FY | - CHF | -6.0% |
| 2004 FY | - CHF | 0.0% |
| Name | Eps | Eps Difference |
|---|